Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 3 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol. 2023 Dec;203(5):781-791. doi: 10.1111/bjh.19058. Epub 2023 Sep 11.
Br J Haematol. 2023.
PMID: 37697469
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Perusini MA, Andrews C, Atenafu EG, Gupta V, Maze D, Schuh AC, Yee KW, Bankar A, Davidson MB, Richard-Carpentier G, Chan SM, Sibai J, Schimmer AD, Minden MD, Sibai H.
Perusini MA, et al.
Hematology. 2024 Dec;29(1):2329027. doi: 10.1080/16078454.2024.2329027. Epub 2024 Mar 25.
Hematology. 2024.
PMID: 38526239
Item in Clipboard
Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report.
Sibai J, Chen R, Nabhani IA, Perusini MA, Sibai H.
Sibai J, et al. Among authors: perusini ma.
EJHaem. 2022 Aug 4;3(4):1374-1376. doi: 10.1002/jha2.541. eCollection 2022 Nov.
EJHaem. 2022.
PMID: 36467820
Free PMC article.
Item in Clipboard
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.
Perusini MA, Andrews C, Eshetu AG, Gupta V, Maze D, Yee KWL, Bankar A, Davidson MB, Richard-Carpentier G, Chan SM, Schimmer AD, Sibai J, Alharbi S, Lucero JA, Linn SM, Minden MD, Schuh AC, Sibai H.
Perusini MA, et al.
Leukemia. 2024 Apr;38(4):912-913. doi: 10.1038/s41375-024-02201-1. Epub 2024 Mar 2.
Leukemia. 2024.
PMID: 38431747
No abstract available.
Item in Clipboard
Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients.
González JS, Perusini MA, Basquiera AL, Alfonso G, Fantl D, Lima WM, Nucifora E, Lazzarino C, Novoa V, de Andrade Silva MC, Larripa IB, Rocha V, Arbelbide J, Velloso EDRP, Belli CB.
González JS, et al. Among authors: perusini ma.
Ann Hematol. 2021 Jun;100(6):1439-1449. doi: 10.1007/s00277-021-04539-3. Epub 2021 May 1.
Ann Hematol. 2021.
PMID: 33932168
Item in Clipboard
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.
Perusini MA, Žáčková D, Kim T, Pagnano K, Pavlovsky C, Ježíšková I, Kvetková A, Jurček T, Kim J, Yoo Y, Yi S, Lee H, Kim KH, Chang M, Capo-Chichi JM, Medeiros JJF, Arruda A, Minden M, Zhang Z, Abelson S, Mayer J, Hwan Kim DD.
Perusini MA, et al.
Blood Adv. 2024 May 28;8(10):2361-2372. doi: 10.1182/bloodadvances.2023012127.
Blood Adv. 2024.
PMID: 38447114
Free PMC article.
Item in Clipboard
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patients.
Lazzarino C, Arbelbide J, Schuster S, Crisp R, González J, Tavares R, Perusini MA, Di Stefano M, Pintos N, Espinosa D, Pimentel M, Rosenhain M, Serrano JC, Enrico A, Iastrebner M, Belli CB.
Lazzarino C, et al. Among authors: perusini ma.
Am J Hematol. 2020 Dec;95(12):E323-E326. doi: 10.1002/ajh.25987. Epub 2020 Oct 1.
Am J Hematol. 2020.
PMID: 32864747
Free article.
No abstract available.
Item in Clipboard
Cite
Cite